A Crucial Dialogue in Guntur: Unraveling the Complexities of Peripheral Neuropathy

A significant medical event recently brought together around 200 dedicated doctors, neurologists, and faculty from across Andhra Pradesh and Telangana. This wasn't just any gathering; it was the Lalitha CME Series on 'Advances in Peripheral Neuropathy,' hosted with great care by the Lalitha PVS Institute of Medical Sciences right there in Guntur on Sunday, September 6, 2026. The atmosphere was certainly buzzing with a shared commitment to deepen understanding and improve patient outcomes for this often debilitating condition.

Peripheral neuropathy, you see, is far more common than many might realize. It's estimated to affect about 1% of the general population, which, when you think about it, is quite a substantial number. But here's where it really hits home: for adults over 60, this figure leaps to a staggering 10%. And guess what one of the biggest culprits is? Diabetes. About half of all peripheral neuropathy cases are linked to diabetes, making it a critical area of focus for prevention and management.

The discussions were incredibly rich, touching on everything from new disorders to advanced diagnostic methods. Dr. Satish Khadilkar from Bombay Hospital, Mumbai, for instance, offered invaluable insights into immune-mediated neuropathies. He highlighted how cutting-edge tools like MR Neurography and nerve ultrasound are truly revolutionizing our ability to diagnose these complex conditions with greater precision. It’s exciting to think about the progress being made!

But beyond the established forms, the medical world is also grappling with newer, intriguing nerve disorders. Speakers at the CME delved into 'nodopathies' and 'paranodopathies,' conditions that can manifest with unsettling symptoms like unsteadiness in gait, tremors, and a rapid weakening of all four limbs. Imagine the impact that could have on someone's daily life; it underscores the urgency of understanding and addressing these challenges.

Dr. P. Vijaya, who is the Managing Director and HOD of Neurosciences, truly stressed the paramount importance of early recognition. "Proper evaluation and timely treatment are absolutely crucial," she emphasized. It's a sentiment echoed by many, because catching these conditions early can make all the difference in a patient's journey.

When it comes to diabetic neuropathy, specifically, Dr. R. Muralidhar Reddy from Hyderabad provided practical, actionable advice. His counsel centered on prevention – a truly vital aspect. He underscored the need for good glycaemic control, diligent management of cholesterol, obesity, and hypertension, and, of course, the enduring power of regular exercise. Beyond prevention, he also introduced spinal cord stimulation as an evidence-based neuromodulation option for treatment, offering a beacon of hope for those suffering.

The conversation wasn't limited to a single cause, though. Dr. Y. Shirisha from NIMS reminded everyone that neuropathies can stem from a wonderfully diverse range of causes. This means that a systematic, thoughtful approach is absolutely essential for accurate diagnosis and effective care. Adding another layer to the discussion, Dr. Madhu Nagappa from NIMHANS brought up the fascinating and somewhat alarming connection between infectious diseases and neuropathies. He spoke about cases linked to COVID-19, Zika, and even enterovirus, showing just how broad the scope of this condition truly is.

The program itself was inaugurated by Chairman P.V. Raghava Sarma, setting a professional and inspiring tone, while Naren Polavarapu did a wonderful job hosting the day's proceedings. All in all, this Guntur CME wasn't just a meeting; it was a powerful exchange of knowledge, a collective push forward in understanding and combating peripheral neuropathy, and a clear sign of the medical community's unwavering dedication to patient well-being.